MoneyWorks4Me

Dr. Reddy's Laboratories informs about completion of auditing

29 Jan 2020 Evaluate
Dr. Reddy's Laboratories has informed that the audit of its API manufacturing plant at Srikakulam, Andhra Pradesh (CTO VI), by the US FDA, has been completed on January 28, 2020. The company has been issued a Form 483 with 5 observations. It will address them comprehensively within the stipulated timeline.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..